TBPH
Theravance Biopharma Inc
$9.17
Earnings Summary
Revenue | $17.57Mn |
Net Profits | $-8.51Mn |
Net Profit Margins | -48.45% |
Highlights
Theravance Biopharma Inc’s revenue jumped 19.91% since last year same period to $17.57Mn in the Q4 2023. On a quarterly growth basis, Theravance Biopharma Inc has generated 11.93% jump in its revenue since last 3-months.
Theravance Biopharma Inc’s net profit jumped 40.31% since last year same period to $-8.51Mn in the Q4 2023. On a quarterly growth basis, Theravance Biopharma Inc has generated 4.91% jump in its net profits since last 3-months.
Theravance Biopharma Inc’s net profit margin jumped 50.22% since last year same period to -48.45% in the Q4 2023. On a quarterly growth basis, Theravance Biopharma Inc has generated 15.04% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Theravance Biopharma Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.25 |
EPS Estimate Current Year | -0.25 |
Highlights
Theravance Biopharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a -66.67% fall from last quarter’s estimates.
Theravance Biopharma Inc’s earning per share (EPS) estimates for the current year stand at -0.25.
Key Ratios
Key ratios of the Theravance Biopharma Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.17 |
Highlights
Theravance Biopharma Inc’s earning per share (EPS) fell -13.33% since last year same period to -0.17 in the Q4 2023. This indicates that the Theravance Biopharma Inc has generated -13.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-09 | -0.21 | -0.17 | 19.05% |
2023-08-09 | -0.21 | -0.28 | -33.33% |
2024-03-01 | -0.15 | -0.17 | -13.33% |
2023-05-10 | -0.26 | -0.35 | -34.62% |
₹0 US Stocks a/c Opening Fee